Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-04-23
DOI
10.3389/fimmu.2020.00717
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Phase 1 Randomized, Placebo-controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of Inactivated Streptococcus pneumoniae Whole-cell Vaccine in Adults
- (2020) Cheryl A. Keech et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults
- (2019) Helen L. Stacey et al. Human Vaccines & Immunotherapeutics
- Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to 23-valent pneumococcal polysaccharide in immunocompetent adults: A systematic review and meta-analysis
- (2019) Nirma Khatri Vadlamudi et al. VACCINE
- Human CD8+ T cell cross-reactivity across influenza A, B and C viruses
- (2019) Marios Koutsakos et al. NATURE IMMUNOLOGY
- Immunogenicity of aIIV3, MF59-Adjuvanted Seasonal Trivalent Influenza Vaccine, in Older Adults ≥65 Years of Age: Meta-Analysis of Cumulative Clinical Experience
- (2019) Uwe Nicolay et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: a Phase III, Randomized Clinical Trial
- (2019) Peter Vink et al. CLINICAL INFECTIOUS DISEASES
- The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and VZV-Specific T Cell Immunity
- (2019) Adriana Weinberg et al. JOURNAL OF VIROLOGY
- Effect of latent cytomegalovirus infection on the antibody response to influenza vaccination: a systematic review and meta-analysis
- (2019) S. P. H. van den Berg et al. MEDICAL MICROBIOLOGY AND IMMUNOLOGY
- Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: a review
- (2019) Marie-Aleth Lacaille-Dubois PHYTOMEDICINE
- Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity
- (2019) Shuting Shi et al. VACCINE
- OMIC Technologies and Vaccine Development: From the Identification of Vulnerable Individuals to the Formulation of Invulnerable Vaccines
- (2019) Nicola Cotugno et al. Journal of Immunology Research
- Pneumococcal vaccination coverages by age, sex and specific underlying risk conditions among middle-aged and older adults in Catalonia, Spain, 2017
- (2019) Angel Vila-Córcoles et al. Eurosurveillance
- Progress in mucosal immunization for protection against pneumococcal pneumonia
- (2019) Viviane Maimoni Gonçalves et al. Expert Review of Vaccines
- Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation
- (2019) Adriana Bastidas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial
- (2019) Robert W Frenck et al. LANCET INFECTIOUS DISEASES
- Impact of age and pre-existing influenza on the induction of human antibody responses against influenza B viruses
- (2019) Michael A. Carlock et al. Human Vaccines & Immunotherapeutics
- Imprinting and Editing of the Human CD4 T Cell Response to Influenza Virus
- (2019) Sean A. Nelson et al. Frontiers in Immunology
- Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE-HSCT)
- (2019) Desmond Curran et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine
- (2019) Thomas C Heineman et al. CURRENT OPINION IN IMMUNOLOGY
- Immunosenescence: A systems-level overview of immune cell biology and strategies for improving vaccine responses
- (2019) Stephen N. Crooke et al. EXPERIMENTAL GERONTOLOGY
- Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis
- (2019) Alemnew F Dagnew et al. LANCET INFECTIOUS DISEASES
- Towards a universal flu vaccine
- (2019) Michael Eisenstein NATURE
- Persistence of immunity to conjugate and polysaccharide pneumococcal vaccines in frail, hospitalised older adults in long-term follow up
- (2019) C. Raina MacIntyre et al. VACCINE
- Immunosenescence and human vaccine immune responses
- (2019) Stephen N. Crooke et al. Immunity & Ageing
- Aging and influenza vaccine-induced immunity
- (2019) Haley L. Dugan et al. CELLULAR IMMUNOLOGY
- End of season influenza vaccine effectiveness in primary care in adults and children in the United Kingdom in 2018/19
- (2019) Richard G. Pebody et al. VACCINE
- Protection provided by influenza vaccine against influenza-related hospitalisation in ≥65 year olds: Early experience of introduction of a newly licensed adjuvanted vaccine in England in 2018/19
- (2019) Richard Pebody et al. VACCINE
- LTA1 is a safe, intranasal enterotoxin-based adjuvant that improves vaccine protection against influenza in young, old and B-cell-depleted (μMT) mice
- (2019) E. Valli et al. Scientific Reports
- Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
- (2019) Almea Matanock et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Comparative Immunogenicity of Several Enhanced Influenza Vaccine Options for Older Adults: A Randomized, Controlled Trial
- (2019) Benjamin J Cowling et al. CLINICAL INFECTIOUS DISEASES
- The impact of aging on CD4+ T cell responses to influenza infection
- (2018) Erica C. Lorenzo et al. BIOGERONTOLOGY
- Adjuvant strategies to improve vaccination of the elderly population
- (2018) Birgit Weinberger CURRENT OPINION IN PHARMACOLOGY
- Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage
- (2018) Shahzma Merani et al. EXPERIMENTAL GERONTOLOGY
- Inflammation and neutrophil immunosenescence in health and disease: Targeted treatments to improve clinical outcomes in the elderly
- (2018) William Drew et al. EXPERIMENTAL GERONTOLOGY
- Intrinsic and extrinsic contributors to defective CD8+ T cell responses with aging
- (2018) Mladen Jergović et al. EXPERIMENTAL GERONTOLOGY
- Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis
- (2018) Jason K. H. Lee et al. Expert Review of Vaccines
- Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older
- (2018) Anthony L Cunningham et al. JOURNAL OF INFECTIOUS DISEASES
- Age-associated Changes in the Respiratory Epithelial Response to Influenza Infection
- (2018) Kelly D Chason et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
- (2018) A Danielle Iuliano et al. LANCET
- Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study
- (2018) Shamez N Ladhani et al. LANCET INFECTIOUS DISEASES
- The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates
- (2018) Natalie I Mazur et al. LANCET INFECTIOUS DISEASES
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- (2018) Evelina Tacconelli et al. LANCET INFECTIOUS DISEASES
- Streptococcus pneumoniae: transmission, colonization and invasion
- (2018) Jeffrey N. Weiser et al. NATURE REVIEWS MICROBIOLOGY
- Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
- (2018) Giuseppe Del Giudice et al. SEMINARS IN IMMUNOLOGY
- Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults
- (2018) Sam Jackson et al. VACCINE
- Post hoc analysis of the efficacy of the 13-valent pneumococcal conjugate vaccine against vaccine-type community-acquired pneumonia in at-risk older adults
- (2018) José A. Suaya et al. VACCINE
- Towards a universal influenza vaccine: different approaches for one goal
- (2018) Giuseppe A. Sautto et al. Virology Journal
- Human cytomegalovirus infection and coronary heart disease: a systematic review
- (2018) Yu Du et al. Virology Journal
- Adjuvanted influenza vaccines
- (2018) John S. Tregoning et al. Human Vaccines & Immunotherapeutics
- The establishment of surrogates and correlates of protection: Useful tools for the licensure of effective influenza vaccines?
- (2018) Brian J. Ward et al. Human Vaccines & Immunotherapeutics
- Persistence of immune response to an adjuvanted varicella-zoster virus subunit vaccine for up to year nine in older adults
- (2018) Tino F. Schwarz et al. Human Vaccines & Immunotherapeutics
- IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration
- (2018) Yoshihiko Terauchi et al. Human Vaccines & Immunotherapeutics
- Vaccines for the elderly: current use and future challenges
- (2018) Birgit Weinberger Immunity & Ageing
- The Elusive Anti-Candida Vaccine: Lessons From the Past and Opportunities for the Future
- (2018) Gloria Hoi Wan Tso et al. Frontiers in Immunology
- An Explorative Biomarker Study for Vaccine Responsiveness after a Primary Meningococcal Vaccination in Middle-Aged Adults
- (2018) Marieke van der Heiden et al. Frontiers in Immunology
- T follicular helper cell development and functionality in immune ageing
- (2018) Claire E. Gustafson et al. CLINICAL SCIENCE
- Persistence of Varicella-Zoster Virus Cell-Mediated Immunity After the Administration of a Second Dose of Live Herpes Zoster Vaccine
- (2018) Adriana Weinberg et al. JOURNAL OF INFECTIOUS DISEASES
- Influenza Vaccination in Older Adults: Recent Innovations and Practical Applications
- (2018) Melissa K. Andrew et al. DRUGS & AGING
- A novel, multiple-antigen pneumococcal vaccine protects against lethal Streptococcus pneumoniae challenge
- (2018) Win-Yan Chan et al. INFECTION AND IMMUNITY
- Vaccination in the elderly: The challenge of immune changes with aging
- (2018) Annalisa Ciabattini et al. SEMINARS IN IMMUNOLOGY
- Estimating costs and health outcomes of publicly funded tick-born encephalitis vaccination: A cost-effectiveness analysis
- (2018) Jad Shedrawy et al. VACCINE
- Panproteome-wide analysis of antibody responses to whole cell pneumococcal vaccination
- (2018) Joseph J Campo et al. eLife
- Mini-HA Is Superior to Full Length Hemagglutinin Immunization in Inducing Stem-Specific Antibodies and Protection Against Group 1 Influenza Virus Challenges in Mice
- (2018) Joan E. M. van der Lubbe et al. Frontiers in Immunology
- Pneumococcal whole-cell and protein-based vaccines: changing the paradigm
- (2017) Michael E. Pichichero Expert Review of Vaccines
- Repeated annual influenza vaccination and vaccine effectiveness: review of evidence
- (2017) Edward A. Belongia et al. Expert Review of Vaccines
- Cohort study on maternal cytomegalovirus seroprevalence and prevalence and clinical manifestations of congenital infection in China
- (2017) Shiwen Wang et al. MEDICINE
- Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae
- (2017) Kosuke Kataoka et al. MICROBIOLOGY AND IMMUNOLOGY
- Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older
- (2017) Lisa M. Dunkle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Personalized vaccinology: A review
- (2017) G.A. Poland et al. VACCINE
- Estimating influenza vaccine effectiveness: Evolution of methods to better understand effects of confounding in older adults
- (2017) Janet E. McElhaney et al. VACCINE
- Efficacy and safety of high-dose influenza vaccine in elderly adults: A systematic review and meta-analysis
- (2017) Krista Wilkinson et al. VACCINE
- IL-17A and complement contribute to killing of pneumococci following immunization with a pneumococcal whole cell vaccine
- (2017) Ivana B. Campos et al. VACCINE
- Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis
- (2017) Alexander Domnich et al. VACCINE
- The road to a more effective influenza vaccine: Up to date studies and future prospects
- (2017) Kaori Sano et al. VACCINE
- Intranasal Administration of Whole Inactivated Influenza Virus Vaccine as a Promising Influenza Vaccine Candidate
- (2017) Akira Ainai et al. VIRAL IMMUNOLOGY
- Cellular immune responses of older adults to four influenza vaccines: Results of a randomized, controlled comparison
- (2017) Arun Kumar et al. Human Vaccines & Immunotherapeutics
- Immunogenicity, safety and tolerability of intradermal influenza vaccines
- (2017) Ivan F. N. Hung et al. Human Vaccines & Immunotherapeutics
- A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60–85 years old) and very elderly (>85 years old) institutionalized subjects
- (2017) Emilia Nunzi et al. Human Vaccines & Immunotherapeutics
- Long-term maintenance of diphtheria-specific antibodies after booster vaccination is hampered by latent infection with Cytomegalovirus
- (2017) Birgit Weinberger et al. Immunity & Ageing
- Role of Dendritic Cells in Inflammation and Loss of Tolerance in the Elderly
- (2017) Anshu Agrawal et al. Frontiers in Immunology
- Lysosome-Dependent Activation of Human Dendritic Cells by the Vaccine Adjuvant QS-21
- (2017) Iain Welsby et al. Frontiers in Immunology
- Pneumococcal Vaccination Among Medicare Beneficiaries Occurring After the Advisory Committee on Immunization Practices Recommendation for Routine Use Of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults Aged ≥65 Years
- (2017) Carla L. Black et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity
- (2017) Margherita Coccia et al. npj Vaccines
- Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis
- (2017) Gerhard Falkenhorst et al. PLoS One
- A dynamic relationship between mucosal T helper type 17 and regulatory T-cell populations in nasopharynx evolves with age and associates with the clearance of pneumococcal carriage in humans
- (2016) A. Mubarak et al. CLINICAL MICROBIOLOGY AND INFECTION
- Biological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective
- (2016) Lindsay Kim et al. CLINICAL MICROBIOLOGY REVIEWS
- Aging of the immune system: Focus on inflammation and vaccination
- (2016) Marcello Pinti et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- I-MOVE multicentre case–control study 2010/11 to 2014/15: Is there within-season waning of influenza type/subtype vaccine effectiveness with increasing time since vaccination?
- (2016) Esther Kissling et al. Eurosurveillance
- Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: A systematic review
- (2016) Marlies Weltevrede et al. EXPERIMENTAL GERONTOLOGY
- Adjuvant system AS01: helping to overcome the challenges of modern vaccines
- (2016) Arnaud M. Didierlaurent et al. Expert Review of Vaccines
- The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis
- (2016) Eili Y. Klein et al. Influenza and Other Respiratory Viruses
- Cross-protective mucosal immunity mediated by memory Th17 cells against Streptococcus pneumoniae lung infection
- (2016) Y Wang et al. Mucosal Immunology
- Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
- (2016) Anthony L. Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
- The generation of memory B cells is maintained, but the antibody response is not, in the elderly after repeated influenza immunizations
- (2016) Daniela Frasca et al. VACCINE
- Corrigendum to “The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50years of age and older: A systematic review and meta-analysis” [Vaccine 34 (2016) 1540–1550]
- (2016) Hannah Kraicer-Melamed et al. VACCINE
- Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: A systematic review and meta-analysis of randomized trials
- (2016) Wen-qi Diao et al. VACCINE
- Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination
- (2016) Slim Fourati et al. Nature Communications
- Viral vector-based influenza vaccines
- (2016) Rory D. de Vries et al. Human Vaccines & Immunotherapeutics
- Macrolide Resistance in Streptococcus pneumoniae
- (2016) Max R. Schroeder et al. Frontiers in Cellular and Infection Microbiology
- Efficacy of PPV23 in Preventing Pneumococcal Pneumonia in Adults at Increased Risk – A Systematic Review and Meta-Analysis
- (2016) Julia Schiffner-Rohe et al. PLoS One
- Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes
- (2016) Theone C. Kon et al. PLoS One
- Central Role of CD169+ Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01
- (2016) Sophie Detienne et al. Scientific Reports
- Clinical Effectiveness of Split-Virion Versus Subunit Trivalent Influenza Vaccines in Older Adults
- (2015) H. K. Talbot et al. CLINICAL INFECTIOUS DISEASES
- Immunogenicity and Safety of Intradermal Influenza Vaccine in the Elderly: A Meta-Analysis of Randomized Controlled Trials
- (2015) Claudia Pileggi et al. DRUGS & AGING
- Dysbiosis of upper respiratory tract microbiota in elderly pneumonia patients
- (2015) Wouter A A de Steenhuijsen Piters et al. ISME Journal
- Naive T Cell Maintenance and Function in Human Aging
- (2015) Jörg J. Goronzy et al. JOURNAL OF IMMUNOLOGY
- Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
- (2015) Himal Lal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
- (2015) Marc J.M. Bonten et al. NEW ENGLAND JOURNAL OF MEDICINE
- A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
- (2015) A. Impagliazzo et al. SCIENCE
- Recent insights into cutaneous immunization: How to vaccinate via the skin
- (2015) Laura Engelke et al. VACCINE
- Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: Randomised, controlled trials
- (2015) Isabel Leroux-Roels et al. VACCINE
- Virus-specific T cells as correlate of (cross-)protective immunity against influenza
- (2015) Arwen F. Altenburg et al. VACCINE
- Safety and tolerability evaluation of the use of Montanide ISA™51 as vaccine adjuvant: A systematic review
- (2015) Eva van Doorn et al. Human Vaccines & Immunotherapeutics
- Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review
- (2015) Barbara Camilloni et al. Human Vaccines & Immunotherapeutics
- Next generation protein basedStreptococcus pneumoniaevaccines
- (2015) Michael E Pichichero et al. Human Vaccines & Immunotherapeutics
- Aging, cytomegalovirus (CMV) and influenza vaccine responses
- (2015) Daniela Frasca et al. Human Vaccines & Immunotherapeutics
- A Molecular Mucosal Adjuvant To Enhance Immunity Against Pneumococcal Infection In The Elderly
- (2015) Yoshiko Fukuyama et al. Immune Network
- Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore
- (2014) Jung Pu Hsu et al. BMC INFECTIOUS DISEASES
- Randomized Controlled Study of the Safety and Immunogenicity of Pneumococcal Vaccine Formulations Containing PhtD and Detoxified Pneumolysin with Alum or Adjuvant System AS02Vin Elderly Adults
- (2014) Karlis Pauksens et al. Clinical and Vaccine Immunology
- Immunogenicity of Intradermal Trivalent Influenza Vaccine With Topical Imiquimod: A Double Blind Randomized Controlled Trial
- (2014) Ivan F. N. Hung et al. CLINICAL INFECTIOUS DISEASES
- Long-term Persistence of Zoster Vaccine Efficacy
- (2014) Vicki A. Morrison et al. CLINICAL INFECTIOUS DISEASES
- B cell function and influenza vaccine responses in healthy aging and disease
- (2014) Daniela Frasca et al. CURRENT OPINION IN IMMUNOLOGY
- Conjugation of a TLR7 agonist and antigen enhances protection in the S. pneumoniae murine infection model
- (2014) S. Vecchi et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Dynamic Changes in the Streptococcus pneumoniae Transcriptome during Transition from Biofilm Formation to Invasive Disease upon Influenza A Virus Infection
- (2014) Melinda M. Pettigrew et al. INFECTION AND IMMUNITY
- Toll-Like Receptor 2-Dependent Protection against Pneumococcal Carriage by Immunization with Lipidated Pneumococcal Proteins
- (2014) Kristin Moffitt et al. INFECTION AND IMMUNITY
- Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: A Phase 1/2a Randomized, Placebo-Controlled Study
- (2014) Elchonon M. Berkowitz et al. JOURNAL OF INFECTIOUS DISEASES
- Antibody blocks acquisition of bacterial colonization through agglutination
- (2014) A M Roche et al. Mucosal Immunology
- Postherpetic Neuralgia
- (2014) Robert W. Johnson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults
- (2014) Carlos A. DiazGranados et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Clinical Trial of the Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine Compared to 23-Valent Polysaccharide Vaccine in Frail, Hospitalized Elderly
- (2014) C. Raina MacIntyre et al. PLoS One
- mTOR inhibition improves immune function in the elderly
- (2014) J. B. Mannick et al. Science Translational Medicine
- Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study
- (2014) Roman Chlibek et al. VACCINE
- Controlled Human Infection and Rechallenge withStreptococcus pneumoniaeReveals the Protective Efficacy of Carriage in Healthy Adults
- (2013) Daniela M. Ferreira et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Vaccine Effectiveness Against Laboratory-Confirmed Influenza Hospitalizations Among Elderly Adults During the 2010-2011 Season
- (2013) J. C. Kwong et al. CLINICAL INFECTIOUS DISEASES
- Pneumococcal infection in adults: burden of disease
- (2013) J.J.C. Drijkoningen et al. CLINICAL MICROBIOLOGY AND INFECTION
- Influenza virosomes as vaccine adjuvant and carrier system
- (2013) Christian Moser et al. Expert Review of Vaccines
- Pneumococcal vaccine and opsonic pneumococcal antibody
- (2013) Joon Young Song et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults >=50 Years of Age
- (2013) R. Chlibek et al. JOURNAL OF INFECTIOUS DISEASES
- Molecular signatures of antibody responses derived from a systems biology study of five human vaccines
- (2013) Shuzhao Li et al. NATURE IMMUNOLOGY
- The global epidemiology of herpes zoster
- (2013) B. P. Yawn et al. NEUROLOGY
- A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA
- (2013) Sharon E. Frey et al. VACCINE
- Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40–70 years of age
- (2013) William L. Heyward et al. VACCINE
- Cross-protection against drifted influenza viruses
- (2013) Andrea Orsi et al. Human Vaccines & Immunotherapeutics
- Safety, immunogenicity, and tolerability of three influenza vaccines in older adults
- (2013) David W. Scheifele et al. Human Vaccines & Immunotherapeutics
- Experimental Human Pneumococcal Carriage Augments IL-17A-dependent T-cell Defence of the Lung
- (2013) Adam K. A. Wright et al. PLoS Pathogens
- Clinical factors associated with the humoral immune response to influenza vaccination in chronic obstructive pulmonary disease
- (2013) Karthik Nath et al. International Journal of Chronic Obstructive Pulmonary Disease
- Development of a Fourfold Multiplexed Opsonophagocytosis Assay for Pneumococcal Antibodies against Additional Serotypes and Discovery of Serological Subtypes in Streptococcus pneumoniae Serotype 20
- (2012) Robert L. Burton et al. Clinical and Vaccine Immunology
- Efficacy, Safety, and Tolerability of Herpes Zoster Vaccine in Persons Aged 50-59 Years
- (2012) K. E. Schmader et al. CLINICAL INFECTIOUS DISEASES
- A Meta-analysis of intradermal versus intramuscular influenza vaccines: Immunogenicity and Adverse Events
- (2012) Fawziah Marra et al. Influenza and Other Respiratory Viruses
- A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults
- (2012) Isabel Leroux-Roels et al. JOURNAL OF INFECTIOUS DISEASES
- Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones and macrolides
- (2012) J.E. Cornick et al. MICROBES AND INFECTION
- Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans
- (2012) Tom M Wilkinson et al. NATURE MEDICINE
- Matrix-M™ Adjuvant Induces Local Recruitment, Activation and Maturation of Central Immune Cells in Absence of Antigen
- (2012) Jenny M. Reimer et al. PLoS One
- Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice
- (2012) Najoua Dendouga et al. VACCINE
- Immunization of newborns with bacterial conjugate vaccines
- (2012) Anita H.J. van den Biggelaar et al. VACCINE
- Low opsonic activity to the infecting serotype in pediatric patients with invasive pneumococcal disease
- (2012) Tomohiro Oishi et al. VACCINE
- Human Nasal Challenge with Streptococcus pneumoniae Is Immunising in the Absence of Carriage
- (2012) Adam K. A. Wright et al. PLoS Pathogens
- Age-Related Changes in Human Peripheral Blood IGH Repertoire Following Vaccination
- (2012) Yu-Chang Bryan Wu et al. Frontiers in Immunology
- Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
- (2011) Nathalie Garçon et al. Expert Review of Vaccines
- Systems biology of vaccination for seasonal influenza in humans
- (2011) Helder I Nakaya et al. NATURE IMMUNOLOGY
- Immunogenicity and safety of inactivated influenza vaccines in primed populations: A systematic literature review and meta-analysis
- (2011) W.E.P. Beyer et al. VACCINE
- Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza–flagellin fusion vaccine (VAX125, STF2.HA1 SI)
- (2011) David N. Taylor et al. VACCINE
- A systematic review of intradermal influenza vaccines
- (2011) Flora Young et al. VACCINE
- Superior Immunogenicity of Inactivated Whole Virus H5N1 Influenza Vaccine is Primarily Controlled by Toll-like Receptor Signalling
- (2011) Felix Geeraedts et al. PLoS Pathogens
- Options for Inactivation, Adjuvant, and Route of Topical Administration of a Killed, Unencapsulated Pneumococcal Whole-Cell Vaccine
- (2010) Y.-J. Lu et al. Clinical and Vaccine Immunology
- Older Adults Have a Low Capacity To Opsonize Pneumococci Due to Low IgM Antibody Response to Pneumococcal Vaccinations
- (2010) Saeyoung Park et al. INFECTION AND IMMUNITY
- H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell Responses
- (2010) Philippe Moris et al. JOURNAL OF CLINICAL IMMUNOLOGY
- The impact of varicella zoster virus: Chronic pain
- (2010) Wim Opstelten et al. JOURNAL OF CLINICAL VIROLOGY
- Safety and Antibody Response, Including Antibody Persistence for 5 Years, after Primary Vaccination or Revaccination with Pneumococcal Polysaccharide Vaccine in Middle‐Aged and Older Adults
- (2010) Daniel M. Musher et al. JOURNAL OF INFECTIOUS DISEASES
- Influence of Age and Nature of Primary Infection on Varicella‐Zoster Virus–Specific Cell‐Mediated Immune Responses
- (2010) Adriana Weinberg et al. JOURNAL OF INFECTIOUS DISEASES
- Decreased antibody titers and booster responses in tick-borne encephalitis vaccinees aged 50–90 years
- (2010) Birgit Weinberger et al. VACCINE
- Clinical and immunologic predictors of influenza illness among vaccinated older adults
- (2010) Zainab Shahid et al. VACCINE
- GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis
- (2010) Ying-Jie Lu et al. VACCINE
- Immune Response in Infants to the Heptavalent Pneumococcal Conjugate Vaccine against Vaccine-Related Serotypes 6A and 19A
- (2009) H. Lee et al. Clinical and Vaccine Immunology
- Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Alaska Native Adults 55–70 Years of Age
- (2009) Karen M. Miernyk et al. CLINICAL INFECTIOUS DISEASES
- Efficacy of Inactivated Split‐Virus Influenza Vaccine against Culture‐Confirmed Influenza in Healthy Adults: A Prospective, Randomized, Placebo‐Controlled Trial
- (2009) Jiri Beran et al. JOURNAL OF INFECTIOUS DISEASES
- Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
- (2009) Tamara Pilishvili et al. JOURNAL OF INFECTIOUS DISEASES
- Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels
- (2009) G. Galli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of Ageing and Gender on Naturally Acquired Antibodies to Pneumococcal Capsular Polysaccharides and Virulence-Associated Proteins
- (2008) B. Simell et al. Clinical and Vaccine Immunology
- Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immunological Memory
- (2008) Andrés de Roux et al. CLINICAL INFECTIOUS DISEASES
- Varicella‐Zoster Virus–Specific Immune Responses in Elderly Recipients of a Herpes Zoster Vaccine
- (2008) M. J. Levin et al. JOURNAL OF INFECTIOUS DISEASES
- Effectiveness of Inactivated Influenza Vaccines Varied Substantially with Antigenic Match from the 2004–2005 Season to the 2006–2007 Season
- (2008) Edward A. Belongia et al. JOURNAL OF INFECTIOUS DISEASES
- Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses
- (2008) Stephen B. Gordon et al. VACCINE
- Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers
- (2008) Pierre Vandepapelière et al. VACCINE
- In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses
- (2008) Mary Dawn T. Co et al. VACCINE
- Immunological responses to pneumococcal vaccine in frail older people
- (2008) I. Ridda et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started